Report Description Table of Contents In 2020, the valuation of the Global Apheresis Market was $ 1.83 billion. It is predicted to reach $ 3.34 billion by 2028, representing a CAGR of 7.78 percent throughout the period of 2020-2028. Apheresis is defined as a medical procedure that involves the purification of blood or the separation of distinct blood components. It includes removing of blood from a donor or patient through the process of Venipuncture and collecting it in an equipment that separates the desired component from the blood. The rest of the blood and other components are returned to the donor or patient at the end of the procedure. Granulocytes are collected during the process to look for infections that are resistant to antibiotics. By the usage of centrifugation or membrane filtration technology, the entire blood gets purified, separating it from the blood components. This technique is regarded as a part of a blood donation procedure and is also done to treat various medical conditions. Leukoreduction is a common phenomenon performed during the process. Also, the peripheral blood mononuclear cells collected from the original allograft donors during the procedure of apheresis are used for donor lymphocytes infusions. According to The American Society for Apheresis, there are over 87 diseases that can be treated with apheresis as a supportive treatment. Furthermore, according to U.S. National Library of Medicine, there are roughly 47 clinical trials related to apheresis for various hematological diseases across the United States as of January 21, 2021. In the year 2015, the Institute of Hematology and Transfusion Medicine signed seven contracts with the Mazovian region's National Health-Funding Authority (NFZ) for public health care services worth a total of 29,542,555 USD. Considering the above statistics, the Apheresis market is going to grow at a rapid pace during the forecasted period. Covid-19 impact on Apheresis Market Due to the vast use of plasma therapy in treating COVID-19 infected patients, the market is highly benefited during the COVID-19 pandemic. In addition, the US FDA approved emergency use authorization (EUA) of convalescent plasma (CCP) therapy in hospitalized COVID-19 patients in August 2020. As a result of this massive usuage of apheresis units in the treatment of COVID-19 patients and growing FDA product approvals, the apheresis industry is expected to rise throughout the pandemic. Market Drivers Increased demand for various blood components, the rising number of accidents worldwide, and increased government initiatives toward blood donation are some of the key drivers driving the worldwide market's growth. Rising prevalence of several therapeutic procedures like red cell exchange (nonsurgical therapy), Fluid replacement therapy, car T cells therapy, dendritic cells cancer therapy and extracorporeal therapy are widely stimulating the entire market growth. The increasing occurrences of chronic diseases, the increasing number of trauma and injury cases, the increasing demand for blood components and growing awareness about blood safety, the rise in the number of complex surgical processes, and favourable reimbursement policies for apheresis procedures are all driving the market. Market Restraint A paucity of qualified specialists and problems related to the apheresis method is projected to stifle the market expansion. Also, due to Apheresis the rising prevalence of the various disorders and diseases like Waldenstrom's macroglobulinemia, growth of germ cell tumours from stem cells of the germ line and early embroyo, Myasthenia gravis, Guillain-Barré syndrome, HyperviscositySyndromes, Paraproteinemia, Cryoglobulinemia,sarcom, Goodpasture's syndrome, symptomatic myeloma, amyloidosis, and non-Hodgkin’s lymphoma are widely restraining the overall growth of the market. Market Opportunity A surge in demand for plasma-derived medications presents significant market expansion opportunities. The rise in the incidence of chronic diseases, the increase in surgical operations, and the rising number of occurrences of accident or injury are all contributing to the market's growth. Market Segmentation BY PRODUCT Apheresis Devices Centrifugal Apheresis Devices Membrane Separation Devices Software Disposable and Reagents BY END-USER Blood collection centres and blood component providers Hospitals and transfusion centers Others BY APPLICATION Plasmapheresis Plateletpheresis (Thrombocytapheresis) Erythrocytapheresis Leukapheresis Photopheresis Others BY TECHNOLOGY Centrifugation Intermittent Flow Centrifugation Continuous Flow Centrifugation Membrane Separation Selective Adsorption By Region North America U.S. Canada Mexico Europe Germany France Italy Switzerland UK Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA In 2020, Based on product, disposables and reagents had maximized its revenue, and this trend is expected to continue throughout the forcasted period. Furthermore, the centrifugal apheresis devices category is expected to develop at the fastest CAGR during the forecasted period. The market for centrifugal apheresis devices is growing due to the advantages of centrifugation over other methods and its efficiency in distinguishing all types of blood components. Based on End-Users, the market segment Blood collection centres and blood component providers possessed 67.5 percent of the worldwide market in 2020. It is due to the expanding number of blood components testing devices, the growing number of bloodcenters, and increased awareness of blood collection centers. Based on the Application, Plasmapheresis possessed the largest market share, accounting for nearly 50.0 percent of the total market in 2020. Plasmapheresis, invented by Grifols in 1951, is a procedure for separating plasma from blood cells. The rising incidence of blood-related illnesses and the growing demand for plasma-derived therapies are the key growth drivers for the market. Based on Technology, the Centrifugation process accounted for the largest market share and is projected to continue over the forecasted period. This is due to the widespread use of centrifugation in the single-step heavy spin preparation of blood components such as packed red blood cells (PRBCs) and fresh frozen plasma (FFP). Membrane separation is anticipated to expand faster over the projected period, as membrane filters are essential for separating plasma from other cellular components to achieve precise cell separation. North America possesses the highest proportion of the market share. The increased occurrence of blood-related diseases such as kidney disease, cancer, and neurological disorders and the presence of developed healthcare infrastructure and high patient awareness levels are the primary drivers that are propelling the market's growth in North America. According to the Centers for Disease Control and Prevention (CDC) 2019 study, chronic kidney disease affects about 37 million (15%) people in the United States (CKD). Moreover, the Europe apheresis equipment market is expected to expand at a CAGR of around 6.39 % throughout the anticipated period of 2020-2028. According to the Leukemia& Lymphoma Society (LLS), one person in the United States is diagnosed with blood cancer every three minutes. In addition, according to the ASCO Post, New cases of Leukemia, lymphoma, and myeloma made up 9.9% of the anticipated 1,806,590 new cancer cases diagnosed in the United States in 2020. Competitive Analysis Key Market Players in the market are as follows : Kawasumi Laboratories Asahi Kasei Medical Kaneka Corporation Cerus Corporation Terumo BCT B. Braun Melsungen AG Haemonetics Corporation Nikkiso HemaCare Corporation Fresenius Kabi Recent Developments On January 20, 2021, Haemonetics Corporation, a global medical technology firm, signed a definitive deal to acquire privately-held Cardiva Medical, a leading vascular closure device manufacturer in Santa Clara, California. On June 3, 2020, Haemonetics Corporation, a global medical technology business, has agreed to sell its manufacturing assets in Fajardo, Puerto Rico, to GVS, a leading producer of sophisticated filtration solutions for critical applications. In August 2020, The Drugs Controller General of India (DGCI) approved the use of apheresis equipment to remove blood plasma for critically ill COVID-19 patients in Goa. The key products that are developed by Apheresis market leaders Name of the product Function Key Players Potassium Adsorption Filter It adsorbs and removesthe excess potassium from packed red blood cells that have been irradiated or preserved for a long-time using SAG-M preservative solution (RBC-SAGM). Kawasumi Laboratories Spectra Optia Apheresis System It's a next-generation therapeutic apheresis and cell collection platform that frees up time for operators to focus on patient care. Terumo BCT DBB-EXA and DBB-EXA ES These equipments are compact, user-friendly, and cost-efficient dialysis monitorsthat provide safe and efficient hemodialysis. Nikkiso Frequently Asked Question About This Report Which market segment is leading the product type category of the apheresis market? The disposables and reagents are the leading product type of the market. Which is the leading Technology for apheresis? Centrifugation is the leading Technology for the market. Which is the leading end-user for apheresis? The blood collection centres and blood component providers are the leading end-user for the market. Who are the key players majorly operating in the apheresis market? The key players operating in the market are Kawasumi Laboratories Inc, Asahi Kasei Medical, Kaneka Corporation, Cerus Corporation, Terumo BCT, B. Braun Melsungen AG, Haemonetics Corporation, Nikkiso, HemaCare Corporation, Fresenius Kabi. What is the market size of the apheresis market? The valuation for the Global Market was $ 1.83 billion in 2020. Which region has the largest share in the apheresis market? The North American Region has the largest share in the market. na Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Apheresis Market Segmentation 1.3.2 Geographic Scope Figure 02: Apheresis Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Apheresis Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Apheresis Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure5: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table2: Risk Assessment Chapter 3. Executive Summary 3.1 Apheresis Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Apheresis Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Apheresis Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Apheresis Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Apheresis Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Centrifugal Apheresis Devices to Witness Highest CAGR in Apheresis Market, By Product, During Forecast Period Figure 11: Blood collection centres and blood component providers to Witness Higher CAGR in Apheresis Market for End-User Segment during Forecast Period Figure 12: Plasmapheresis Segment for Application to Register Highest CAGR in Apheresis Market during Forecast Period Figure 13: Centrifugation process to Witness Higher CAGR in Apheresis Market for Technology Segment during Forecast Period Figure 14: North America to Account for Largest Share of Global Apheresis Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 15: Apheresis Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Apheresis Market 5.2.1 Global Apheresis market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Apheresis market, by region, 2020 - 2028 (USD Million) 5.4 Product Segment Analysis 5.4.1 Global Apheresis market, By Product, 2020 - 2028 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Global Apheresis market, By End-User, 2020 - 2028 (USD Million) 5.6 Application Segment Analysis 5.6.1 Global Apheresis market, by Application, 2020 - 2028 (USD Million) 5.7 Technology Segment Analysis 5.7.1 Global Apheresis market, by Technology, 2020 - 2028 (USD Million) 5.8 By Application Business Analysis 5.9 Value Chain Analysis 5.10 Market Variable Analysis 5.10.1 Market Drivers Analysis 5.10.2 Market Restraints Analysis 5.11 Business Environment Analysis Tool 5.11.1 Apheresis market PEST analysis 5.11.2 Apheresis market Porter’s analysis 5.12 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 16 Apheresis Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 17 Apheresis Market Drivers and Their Impact 6.2.2 Restraints Figure 18 Apheresis Market Restraints and Their Impact 6.2.3 Opportunities Figure 19 Apheresis Market Opportunities and Their Impact 6.2.4 Challenges Figure 20 Apheresis Market Challenges and Their Impact 6.3 Impact of Covid-19 on Apheresis Market 6.4 Value Chain Analysis Figure 21 Value Chain Analysis: Apheresis Market 6.5 Ecosystem Figure 22 Apheresis Market: Ecosystem Table 3 Apheresis Market: Ecosystem Figure 23 Revenue Shift in Apheresis Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Apheresis Market in USA in Last 9 Years Figure 24 Top 10 Companies with Highest No. of Patents in Last 9 Years Figure 25 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Apheresis Market 6.7 Trade Analysis 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6 Apheresis Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Application Analysis 6.11.1 Trends in Application (2014-2020) 6.11.2 Trends in Application (2021-2028) Table 7 Key Regulations: Apheresis Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Players market share Figure26: Key players market share of companies 7.2 Manufacturers Apheresis Manufacturing Sites, Area Served, Product Type 7.3 Apheresis Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Apheresis Market: Product Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 9 Apheresis Market, By Product, 2021–2028 (USD Million) Figure 27 Apheresis Market, By Product Figure 28 Centrifugal Apheresis Devices Segment to Register Highest CAGR in Apheresis Market During Forecast Period 8.3 Apheresis Devices 8.3.1 Apheresis Devices market, 2020 - 2028 (USD Million) 8.3.1.1 Centrifugal Apheresis Devices market, 2020 - 2028 (USD Million) 8.3.1.2 Membrane Separation Devices market, 2020 - 2028 (USD Million) Figure 29: Membrane-To-Membrane Systems market, 2020 - 2028 (USD Million) 8.4 Software 8.4.1 Software market, 2020 - 2028 (USD Million) Figure 30: Software market, 2020 - 2028 (USD Million) 8.5 Disposable and Reagents 8.5.1 Disposable and Reagents market, 2020 - 2028 (USD Million) Figure 31: Disposable and Reagents market, 2020 - 2028 (USD Million) Chapter 9. Global Apheresis Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 10: Apheresis Market, By End-User, 2021–2028 (USD Million) Figure 32: Apheresis Market, By End-User, 2021–2028 (USD Million) Figure 33: Blood collection centres and blood component providers Segment to Register Highest CAGR in Apheresis Market during Forecast Period 9.3 Blood collection centres and blood component providers 9.3.1 Blood collection centres and blood component providers market, 2020 - 2028 (USD Million) Figure 34: Blood collection centres and blood component providers market, 2020 - 2028 (USD Million) 9.4 Blood collection centres and blood component providers 9.4.1 Blood collection centres and blood component providers market, 2020 - 2028 (USD Million) Figure 35: Blood collection centres and blood component providers market, 2020 - 2028 (USD Million) 9.5 Hospitals and transfusion centers 9.5.1 Hospitals and transfusion centers market, 2020 - 2028 (USD Million) Figure 36: Hospitals and transfusion centers market, 2020 - 2028 (USD Million) 9.6 Others 9.6.1 Others market, 2020 - 2028 (USD Million) Figure 37: Others market, 2020 - 2028 (USD Million) Chapter 10. Global Apheresis Market: Application Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2020-2028) Table 11: Apheresis Market, By Application, 2021–2028 (USD Million) Figure 38: Apheresis Market, By Application, 2021–2028 (USD Million) Figure 39: Plasmapheresis to Register Highest CAGR in Apheresis Market during Forecast Period 10.3 Plasmapheresis 10.3.1 Plasmapheresis market, 2020 - 2028 (USD Million) Figure 40: Plasmapheresis market, 2020 - 2028 (USD Million) 10.4 Plateletpheresis (Thrombocytapheresis) 10.4.1 Plateletpheresis (Thrombocytapheresis) market, 2020 - 2028 (USD Million) Figure 41: Plateletpheresis (Thrombocytapheresis) market, 2020 - 2028 (USD Million) 10.5 Erythrocytapheresis 10.5.1 Erythrocytapheresis Application market, 2020 - 2028 (USD Million) Figure 42: Erythrocytapheresis Application market, 2020 - 2028 (USD Million) 10.6 Leukapheresis 10.6.1 Leukapheresis Application market, 2020 - 2028 (USD Million) Figure 43: Leukapheresis Application market, 2020 - 2028 (USD Million) 10.7 Photopheresis 10.7.1 Photopheresis Application market, 2020 - 2028 (USD Million) Figure 44: Photopheresis Application market, 2020 - 2028 (USD Million) 10.8 Others 10.8.1 Others Application market, 2020 - 2028 (USD Million) Figure 45: Others Application market, 2020 - 2028 (USD Million) Chapter 11. Global Apheresis Market: Technology Segment Analysis 11.1 Introduction 11.2 Sales Volume & Revenue Analysis (2020-2028) Table 12: Apheresis Market, By Technology, 2021–2028 (USD Million) Figure 46: Apheresis Market, By Technology, 2021–2028 (USD Million) Figure 47: Centrifugation Segment to Register Highest CAGR in Apheresis Market during Forecast Period 11.3 Centrifugation 11.3.1 Centrifugation market, 2020 - 2028 (USD Million) 11.3.1.1 Intermittent Flow Centrifugation market, 2020 - 2028 (USD Million) 11.3.1.2 Continuous Flow Centrifugation market, 2020 - 2028 (USD Million) Figure 48: Centrifugation market, 2020 - 2028 (USD Million) 11.4 Membrane Separation 11.4.1 Membrane Separation market, 2020 - 2028 (USD Million) Figure 49: Membrane Separation market, 2020 - 2028 (USD Million) 11.5 Selective Adsorption 11.5.1 Selective Adsorption market, 2020 - 2028 (USD Million) Figure 50: Selective Adsorption market, 2020 - 2028 (USD Million) Chapter 12. Global Apheresis Market: Regional Outlook 12.1 North America Figure 51: North America Apheresis Market, By Revenue Forecast (2020-2028) 12.1.1 North America Apheresis market, by country, 2020 - 2028 (USD Million) Table 13: North America Apheresis Market, by Country, 2020-2028 Figure 52: North America Apheresis Market 12.1.2 North America Apheresis market, By Product, 2020 - 2028 (USD Million) Table14: North America Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 53: North America Apheresis market, By Product, 2020 - 2028 (USD Million) 12.1.3 North America Apheresis market, by End-User, 2020 - 2028 (USD Million) Table 15: North America Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 54: North America Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.1.4 North America Apheresis market, by Application, 2020 - 2028 (USD Million) Table 16: North America Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 55: North America Apheresis market, by Application, 2020 - 2028 (USD Million) 12.1.5 U.S. 12.1.5.1 U.S. Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 56: U.S. Apheresis market, By Product, 2020 - 2028 (USD Million) 12.5.2 U.S. Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 57: U.S. Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.1.5.3 U.S. Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 58: U.S. Apheresis market, by Application, 2020 - 2028 (USD Million) 12.1.6 Canada 12.1.6.1 Canada Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 59: Canada Apheresis market, By Product, 2020 - 2028 (USD Million) 12.1.6.2 Canada Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 60: Canada Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.1.6.3 Canada Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 61: Canada Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.1.6.4 Canada Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 62: Canada Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.2 Europe Figure 63: Europe Apheresis Market, By Revenue Forecast (2020-2028) 12.2.1 Europe Apheresis market, by country, 2020 - 2028 (USD Million) Table 17: Europe Apheresis market, by country, 2020 - 2028 (USD Million) Figure 64: Europe Apheresis market, by country, 2020 - 2028 (USD Million) 12.2.2 Europe Apheresis market, By Product, 2020 - 2028 (USD Million) Table 18: Europe Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 65: Europe Apheresis market, By Product, 2020 - 2028 (USD Million) 12.2.3 Europe Apheresis market, by End-User, 2020 - 2028 (USD Million) Table 19: Europe Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 66: Europe Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.2.4 Europe Apheresis market, by Application, 2020 - 2028 (USD Million) Table 20: Europe Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 67: Europe Apheresis market, by Application, 2020 - 2028 (USD Million) 12.2.5 U.K. 12.2.5.1 U.K. Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 68: U.K. Apheresis market, By Product, 2020 - 2028 (USD Million) 12.2.5.2 U.K. Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 69: U.K. Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.2.5.3 U.K. Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 70: U.K. Apheresis market, by Application, 2020 - 2028 (USD Million) 12.2.6 Germany 12.2.6.1 Germany Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 71: Germany Apheresis market, By Product, 2020 - 2028 (USD Million) 12.2.6.2 Germany Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 72: Germany Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.2.6.3 Germany Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 73: Germany Apheresis market, by Application, 2020 - 2028 (USD Million) 12.2.7 France 12.2.7.1 France Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 74: France Apheresis market, By Product, 2020 - 2028 (USD Million) 12.2.7.2 France Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 75: France Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.2.7.3 France Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 76: France Apheresis market, by Application, 2020 - 2028 (USD Million) 12.2.8 Rest of Europe 12.2.8.1 Rest of Europe Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 77: Rest of Europe Apheresis market, By Product, 2020 - 2028 (USD Million) 12.2.8.2 Rest of Europe Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 78: Rest of Europe Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.2.8.3 Rest of Europe Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 79: Rest of Europe Apheresis market, by Application, 2020 - 2028 (USD Million) 12.3 Asia Pacific Figure 80: Asia Pacific Apheresis Market, By Revenue Forecast (2020-2028) 12.3.1 Asia Pacific Apheresis market, by country, 2020 - 2028 (USD Million) Table 21: Asia Pacific Apheresis market, by country, 2020 - 2028 (USD Million) Figure 81: Asia Pacific Apheresis market, by country, 2020 - 2028 (USD Million) 12.3.2 Asia Pacific Apheresis market, By Product, 2020 - 2028 (USD Million) Table 22: Asia Pacific Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 82: Asia Pacific Apheresis market, By Product, 2020 - 2028 (USD Million) 12.3.3 Asia Pacific Apheresis market, by End-User, 2020 - 2028 (USD Million) Table 23: Asia Pacific Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 83: Asia Pacific Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.3.4 Asia Pacific Apheresis market, by Application, 2020 - 2028 (USD Million) Table 24: Asia Pacific Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 84: Asia Pacific Apheresis market, by Application, 2020 - 2028 (USD Million) 12.3.5 China 12.3.5.1 China Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 85: China Apheresis market, By Product, 2020 - 2028 (USD Million) 12.3.5.2 China Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 86: China Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.3.5.3 China Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 87: China Apheresis market, by Application, 2020 - 2028 (USD Million) 12.3.6 India 12.3.6.1 India Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 88: India Apheresis market, By Product, 2020 - 2028 (USD Million) 12.3.6.2 India Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 89: India Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.3.6.3 India Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 90: India Apheresis market, by Application, 2020 - 2028 (USD Million) 12.3.7 Japan 12.3.7.1 Japan Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 91: Japan Apheresis market, By Product, 2020 - 2028 (USD Million) 12.3.7.2 Japan Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 92: Japan Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.3.7.3 Japan Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 93: Japan Apheresis market, by Application, 2020 - 2028 (USD Million) 12.3.8 South Korea 12.3.8.1 South Korea Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 94: South Korea Apheresis market, By Product, 2020 - 2028 (USD Million) 12.3.8.2 South Korea Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 95: South Korea Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.3.8.3 South Korea Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 96: South Korea Apheresis market, by Application, 2020 - 2028 (USD Million) 12.3.9 Rest of APAC 12.3.9.1 Rest of APAC Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 97: Rest of APAC Apheresis market, By Product, 2020 - 2028 (USD Million) 12.3.9.2 Rest of APAC Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 98: Rest of APAC Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.3.9.3 Rest of APAC Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 99: Rest of APAC Apheresis market, by Application, 2020 - 2028 (USD Million) 12.4 Latin America Figure 100: Latin America Apheresis Market, By Revenue Forecast (2020-2028) 12.4.1 Latin America Apheresis market, by country, 2020 - 2028 (USD Million) Table 25: Latin America Apheresis market, by country, 2020 - 2028 (USD Million) Figure 101: Latin America Apheresis market, by country, 2020 - 2028 (USD Million) 12.4.2 Latin America Apheresis market, By Product, 2020 - 2028 (USD Million) Table 26: Latin America Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 102: Latin America Apheresis market, By Product, 2020 - 2028 (USD Million) 12.4.3 Latin America Apheresis market, by End-User, 2020 - 2028 (USD Million) Table 27: Latin America Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 103: Latin America Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.4.4 Latin America Apheresis market, by Application, 2020 - 2028 (USD Million) Table 28: Latin America Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 104: Latin America Apheresis market, by Application, 2020 - 2028 (USD Million) 12.4.5 Brazil 12.4.5.1 Brazil Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 105: Brazil Apheresis market, By Product, 2020 - 2028 (USD Million) 12.4.5.2 Brazil Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 106: Brazil Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.4.5.3 Brazil Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 107: Brazil Apheresis market, by Application, 2020 - 2028 (USD Million) 12.4.6 Mexico 12.4.6.1 Mexico Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 108: Mexico Apheresis market, By Product, 2020 - 2028 (USD Million) 12.4.6 2 Mexico Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 109: Mexico Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.4.6.3 Mexico Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 110: Mexico Apheresis market, by Application, 2020 - 2028 (USD Million) 12.4.6.4 Mexico Apheresis market, by By Application, 2020 - 2028 (USD Million) Figure 111: Mexico Apheresis market, by By Application, 2020 - 2028 (USD Million) 12.4.7 Rest of the Latin America 12.4.7.1 Rest of the Latin America Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 112: Rest of the Latin America Apheresis market, By Product, 2020 - 2028 (USD Million) 12.4.7.2 Rest of the Latin America Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 113: Rest of the Latin America Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.4.7.3 Rest of the Latin America Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 114: Rest of the Latin America Apheresis market, by Application, 2020 - 2028 (USD Million) 12.5 MEA Figure 115: MEA Apheresis Market, By Revenue Forecast (2020-2028) 12.5.1 MEA Apheresis market, By Product, 2020 - 2028 (USD Million) Figure 116: MEA Apheresis market, By Product, 2020 - 2028 (USD Million) 12.5.2 MEA Apheresis market, by End-User, 2020 - 2028 (USD Million) Figure 117: MEA Apheresis market, by End-User, 2020 - 2028 (USD Million) 12.5.3 MEA Apheresis market, by Application, 2020 - 2028 (USD Million) Figure 118: MEA Apheresis market, by Application, 2020 - 2028 (USD Million) 12.5.4 MEA Apheresis market, by By Application, 2020 - 2028 (USD Million) Figure 119: MEA Apheresis market, by By Application, 2020 - 2028 (USD Million) Chapter 13. Competitive Landscape 13.1 Kawasumi Laboratories. 13.1.1 Company overview 13.1.2 Financial performance 13.1.3 Product Portfolio Analysis 13.1.4 Business Strategy & Recent Development 13.2 Asahi Kasei Medical. 13.2 .1 Company overview 13.2 .2 Financial performance 13.2 .3 Product Portfolio Analysis 13.2 .4 Business Strategy & Recent Development 13.3 Kaneka Corporation. 13.3.1 Company overview 13.3.2 Financial performance 13.3.3 Product Portfolio Analysis 13.3.4 Business Strategy & Recent Development 13.4 Cerus Corporation. 13.4.1 Company overview 13.4.2 Financial performance 13.4.3 Product Portfolio Analysis 13.4.4 Business Strategy & Recent Development 13.5 Terumo BCT. 13.5.1 Company overview 13.5.2 Financial performance 13.5.3 Product Portfolio Analysis 13.5.4 Business Strategy & Recent Development 13.6 B. Braun Melsungen AG. 13.6.1 Company overview 13.6.2 Financial performance 13.6.3 Product Portfolio Analysis 13.6.4 Business Strategy & Recent Development 13.7 Haemonetics Corporation. 13.7.1 Company overview 13.7.2 Financial performance 13.7.3 Product Portfolio Analysis 13.7.4 Business Strategy & Recent Development 13.8 Nikkiso. 13.8.1 Company overview 13.8.2 Financial performance 13.8.3 Product Portfolio Analysis 13.8.4 Business Strategy & Recent Development 13.9 HemaCare Corporation. 13.9.1 Company overview 13.9.2 Financial performance 13.9.3 Product Portfolio Analysis 13.9.4 Business Strategy & Recent Development 13.10 Fresenius Kabi. 13.10.1 Company overview 13.10.2 Financial performance 13.10.3 Product Portfolio Analysis 13.10.4 Business Strategy & Recent Development